Clinical manufacturing solutions for research in cell and gene therapies
Cell and gene therapy, where and when it matters most
Patients in clinical studies rely on you at a time when they are most vulnerable. That is when our decades of unwavering commitment to advancing the life sciences and cell therapy means the most.
Miltenyi Biotec has been driving progress in cell and gene therapy (CGT) for over 25 years. Helping advance therapies to clinical settings, our expertise in instruments, reagents, and services facilitates fast and standardized point-of-care manufacturing of autologous and allogeneic therapies. We also recognize the dynamic nature of medicine and the importance of staying ahead. Thus, our core competence in innovation focuses on empowering flexible, complete workflows that meet the evolving needs of clinicians.
Whether for immuno-oncology, graft engineering, autoimmune disease, or regenerative medicine, our product portfolio covers workflow steps from cell separation to in-process and quality control, ensuring precise and efficient outcomes. You define what is possible. We help you make it a reality.
View cell and gene therapy solutions by indication
Discover how leading cell therapy centers are implementing point-of-care manufacturing approaches to expand patient access and accelerate innovation
Setting the benchmark in cell and gene therapy solutions
Pioneering more than 200 cell therapy trials with PoC manufacturing and analytics*
Approved engineered T cell therapies are manufactured using Miltenyi Biotec's solutions**
Over 25 years of CGT expertise and relentlessly pushing boundaries
*Active cell therapy trials and hospital treatments using CliniMACS® Instruments for manufacturing and/or analytics of cell products
** Approved cell therapies and gene-modified cell therapies in Europe and USA, excluding minimally manipulated cell therapies, cord blood products, and tissue-engineered therapies
Patients in clinical studies trust you. We have your back.
We prioritize efficacy and safety within the context of real-world, clinical-scale manufacturing settings. That promise goes beyond an instrument purchase. With world-class service and technical support, we understand your unique requirements and help build the infrastructure to meet your intended use and throughput.
The evidence is clear. Our technologies help realize more than 100,000 cell therapy workflows, clinical trials, and treatments for over 6,000 patients annually. Have a look at our reference lists detailing our involvement.
Cell and gene therapy technologies that transform care
Increased accessibility
Imagine a world where life-saving interventions are not always bound by traditional supply chains. Envision care where critical medical cases without access to commercial therapy are prioritized through efficient and accessible Point-of-Care (PoC) manufacturing.
Designed for automated and scalable GMP-compliant cell manufacturing, the CliniMACS Prodigy® Platform helps you and your team make a profound impact on delivering cell and gene therapies. Increase patient access to treatment by reducing vein-to-vein time and eliminating the carbon footprint and expense of off-site logistics through decentralized manufacturing.
Define the next decade of therapy.
Tailored workflows
Realize your PoC manufacturing through our Cell Manufacturing Enabling Package (CMEP), a modular training and support program. Whether you are just starting out or scaling up, move from project launch to full clinical CAR T cell manufacturing in as little as 12 months. Built on more than 25 years of experience in cell and gene therapy, it gives you standardized protocols, adaptable documentation templates, regulatory guidance, and hands-on training. The complete package ensures you can start with confidence and keep moving forward.
When you need a workflow tailored to your specific process requirements, our Customized Application Services team works with you to achieve it. We translate manual protocols into integrated, GMP-compliant processes on the CliniMACS Prodigy. Each project includes workflow design, control documentation, and training to ensure precision at every step.
Reliable analytics
Picture clinical decisions supported by quick and dependable data at the point of care. Achieve consistent in-process control and release testing with analytical solutions designed for decentralized CGT manufacturing.
Our standardized flow cytometry workflows help reduce variability, support regulatory readiness, and generate comparable results across sites, so you can advance therapies with confidence.
Knowledge and experience in cell and gene therapy
Stay ahead in your field
Sign up for our newsletter to keep up to date with latest field developments, case studies, and networking events.
Do you need expert advice? Connect with us today.
You have previously chosen International as your location.
What do you want to do?